MSD acquires WuXi Vaccines' Dundalk facility with a €500 million investment, creating 1,000 new jobs across Ireland and ...

WuXi Biologics Cayman Inc. will sell a vaccine facility in Ireland to Merck & Co. for about $500 million as the Chinese ...

The dvm360 editorial team is counting down our Top 20 news stories and articles of the year, from January 1, 2024, to ...

At present, the vaccine is being studied in combination with Merck's Keytruda (pembrolizumab) for the treatment of high-risk melanoma and other cancers. Phase 2 clinical trials which ended in 2021 ...

including a high number of veterinary clinics and hospitals equipped with state-of-the-art facilities. Additionally, the presence of leading vaccine manufacturers, such as Zoetis and Merck Animal ...

WuXi Biologics’ move to sell the facility could strengthen the company’s cash flow and margins as it navigates global ...

LAS VEGAS, Dec. 10, 2024 /PRNewswire/ -- The veterinary vaccines market is experiencing robust growth driven by factors such as the rising prevalence of zoonotic diseases, increasing concerns ...

Notable veterinary vaccine companies such as Hester Biosciences Limited, Boehringer Ingelheim International GmbH, Zoetis Services LLC, Elanco, Merck & Co., Inc., Indian Immunologicals Ltd., Phibro ...